113 related articles for article (PubMed ID: 2820273)
1. Effects of treatment with cobra venom factor on experimentally induced feline leukemia.
Kraut EH; Rojko JL; Olsen RG; Tuomari DL
Am J Vet Res; 1987 Jul; 48(7):1063-6. PubMed ID: 2820273
[TBL] [Abstract][Full Text] [Related]
2. Effects of cobra venom factor treatment on latent feline leukemia virus infection.
Kraut EH; Rojko JL; Olsen RG; Tuomari DL
J Virol; 1985 Jun; 54(3):873-5. PubMed ID: 2987539
[TBL] [Abstract][Full Text] [Related]
3. Feline oncornavirus-associated cell membrane antigen. VI. Cytotoxic antibody in cats exposed to feline leukemia virus.
Mathes LE; Yohn DS; Hoover EA; Essex M; Schaller JP; Olsen RG
J Natl Cancer Inst; 1976 Jun; 56(6):1197-200. PubMed ID: 186623
[TBL] [Abstract][Full Text] [Related]
4. Remission of FeLV-associated lymphosarcoma and persistent viral infection after extracorporeal immunoadsorption of plasma using staphylococcal protein A columns: details of immune response.
Snyder HW; Reed DE; Jones FR
Semin Hematol; 1989 Apr; 26(2 Suppl 1):25-30. PubMed ID: 2543084
[TBL] [Abstract][Full Text] [Related]
5. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of feline leukemia virus-induced leukemogenesis in cats exposed to methylnitrosourea.
Schaller JP; Mathes LE; Hoover EA; Olsen RG
Int J Cancer; 1979 Nov; 24(5):700-5. PubMed ID: 93586
[TBL] [Abstract][Full Text] [Related]
7. Feline leukemia - unique and cross-relating antigens on individual virus-producing tumors identified by complement-dependent antibody.
Grant CK; Michalek MT
Int J Cancer; 1981 Aug; 28(2):209-17. PubMed ID: 6172390
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus.
Mathes LE; Olsen RG; Hebebrand LC; Hoover EA; Schaller JP; Adams PW; Nichols WS
Cancer Res; 1979 Mar; 39(3):950-5. PubMed ID: 218725
[TBL] [Abstract][Full Text] [Related]
9. Feline leukemia virus infection: age-related variation in response of cats to experimental infection.
Hoover EA; Olsen RG; Hardy WD; Schaller JP; Mathes LE
J Natl Cancer Inst; 1976 Aug; 57(2):365-9. PubMed ID: 187771
[TBL] [Abstract][Full Text] [Related]
10. Feline oncornavirus-associated cell membrane antigen. III. Antibody titers in cats from leukemia cluster households.
Essex M; Jakowski RM; Hardy WD; Cotter SM; Hess P; Sliski A
J Natl Cancer Inst; 1975 Mar; 54(3):637-41. PubMed ID: 164563
[TBL] [Abstract][Full Text] [Related]
11. Complement depletion with humanised cobra venom factor: efficacy in preclinical models of vascular diseases.
Vogel CW; Fritzinger DC; Gorsuch WB; Stahl GL
Thromb Haemost; 2015 Mar; 113(3):548-52. PubMed ID: 25031089
[TBL] [Abstract][Full Text] [Related]
12. Horizontal transmission of feline leukemia virus under natural conditions in a feline leukemia cluster household.
Essex M; Cotter SM; Sliski AH; Hardy WD; Stephenson JR; Aaronson SA; Jarrett O
Int J Cancer; 1977 Jan; 19(1):90-6. PubMed ID: 188773
[TBL] [Abstract][Full Text] [Related]
13. Lysis of feline lymphoma cells by complement-dependent antibodies in feline leukemia virus contact cats. Correlation of lysis and antibodies to feline oncornavirus-associated cell membrane antigen.
Grant CK; Essex M; Pedersen NC; Hardy WD; Stephenson JR; Cotter SM; Theilen GH
J Natl Cancer Inst; 1978 Jan; 60(1):161-6. PubMed ID: 203702
[No Abstract] [Full Text] [Related]
14. Abrogation of resistance to feline oncornavirus disease by immunization with killed feline leukemia virus.
Olsen RG; Hoover EA; Schaller JP; Mathes LE; Wolff LH
Cancer Res; 1977 Jul; 37(7 Pt 1):2082-5. PubMed ID: 67886
[TBL] [Abstract][Full Text] [Related]
15. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
Rojko JL; Hoover EA; Finn BL; Olsen RG
J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
[TBL] [Abstract][Full Text] [Related]
16. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
[TBL] [Abstract][Full Text] [Related]
17. Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow, and saliva of cats.
Hoover EA; Olsen RG; Mathes LE; Schaller JP
Cancer Res; 1977 Oct; 37(10):3707-10. PubMed ID: 198120
[TBL] [Abstract][Full Text] [Related]
18. Influence of adrenal corticosteroids on the susceptibility of cats to feline leukemia virus infection.
Rojko JL; Hoover EA; Mathes LE; Krakowka S; Olsen RG
Cancer Res; 1979 Sep; 39(9):3789-91. PubMed ID: 225025
[TBL] [Abstract][Full Text] [Related]
19. Effect of diethylcarbamazine on serum antibody to feline oncornavirus-associated cell membrane antigen in feline leukemia virus cats.
Kitchen LW; Cotter SM
J Clin Lab Immunol; 1988 Feb; 25(2):101-3. PubMed ID: 2836593
[TBL] [Abstract][Full Text] [Related]
20. Infection with feline leukemia virus associated with induction of humoral response to a normal cell protein.
Chen AP; Essex ME
Cancer Invest; 1984; 2(2):81-90. PubMed ID: 6329486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
